Header Logo

Connection

Shabir Madhi to Streptococcal Infections

Back to Details
This is a "connection" page, showing publications Shabir Madhi has written about Streptococcal Infections.
Shabir Madhi
Connection Strength
17,119
Streptococcal Infections
  1. Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20; 389(3):215-227.
    View in: PubMed
    Score: 0,737
  2. Association of infant Rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive Group B Streptococcal disease in young infants. Vaccine. 2023 03 03; 41(10):1679-1683.
    View in: PubMed
    Score: 0,715
  3. Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B Streptococcal disease. Vaccine. 2021 11 16; 39(47):6813-6816.
    View in: PubMed
    Score: 0,653
  4. Investigation of Possible Nosocomial-Associated Invasive Group B Streptococcus Disease Using Whole-Genome Sequencing: A Report of 3 Cases. J Pediatric Infect Dis Soc. 2021 Sep 23; 10(8):880-882.
    View in: PubMed
    Score: 0,650
  5. Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study. Clin Infect Dis. 2021 09 07; 73(5):e1170-e1180.
    View in: PubMed
    Score: 0,648
  6. The Association Between Breast Milk Group B Streptococcal Capsular Antibody Levels and Late-onset Disease in Young Infants. Clin Infect Dis. 2020 03 03; 70(6):1110-1114.
    View in: PubMed
    Score: 0,583
  7. Surveillance for incidence and etiology of early-onset neonatal sepsis in Soweto, South Africa. PLoS One. 2019; 14(4):e0214077.
    View in: PubMed
    Score: 0,548
  8. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines. Expert Rev Vaccines. 2018 07; 17(7):635-651.
    View in: PubMed
    Score: 0,521
  9. Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy. Sci Rep. 2017 11 28; 7(1):16454.
    View in: PubMed
    Score: 0,499
  10. Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S125-S132.
    View in: PubMed
    Score: 0,497
  11. Prospects for preventing infant invasive GBS disease through maternal vaccination. Vaccine. 2017 08 16; 35(35 Pt A):4457-4460.
    View in: PubMed
    Score: 0,473
  12. Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. PLoS One. 2016; 11(12):e0169101.
    View in: PubMed
    Score: 0,468
  13. Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections. Curr Opin Infect Dis. 2016 06; 29(3):262-7.
    View in: PubMed
    Score: 0,450
  14. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016 09; 16(9):1076-1084.
    View in: PubMed
    Score: 0,449
  15. Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology. PLoS One. 2016; 11(4):e0152524.
    View in: PubMed
    Score: 0,445
  16. Serotype-Specific Cell-Mediated Immunity Associated With Clearance of Homotypic Group B Streptococcus Rectovaginal Colonization in Pregnant Women. J Infect Dis. 2016 06 15; 213(12):1923-6.
    View in: PubMed
    Score: 0,444
  17. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants. Vaccine. 2015 Nov 27; 33(48):6793-9.
    View in: PubMed
    Score: 0,431
  18. Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants. Expert Rev Vaccines. 2015; 14(12):1651-60.
    View in: PubMed
    Score: 0,428
  19. Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries. Vaccine. 2015 Nov 25; 33(47):6396-400.
    View in: PubMed
    Score: 0,425
  20. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One. 2015; 10(4):e0123014.
    View in: PubMed
    Score: 0,415
  21. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
    View in: PubMed
    Score: 0,415
  22. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women. Clin Microbiol Infect. 2015 Jun; 21(6):568.e13-21.
    View in: PubMed
    Score: 0,411
  23. Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy. PLoS One. 2014; 9(6):e98778.
    View in: PubMed
    Score: 0,394
  24. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013 Aug 28; 31 Suppl 4:D52-7.
    View in: PubMed
    Score: 0,371
  25. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One. 2011 Mar 21; 6(3):e17861.
    View in: PubMed
    Score: 0,314
  26. Surface protein distribution in Group B Streptococcus isolates from South Africa and identifying vaccine targets through in silico analysis. Sci Rep. 2024 09 30; 14(1):22665.
    View in: PubMed
    Score: 0,200
  27. Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study. Vaccine. 2024 Jun 11; 42(16):3564-3571.
    View in: PubMed
    Score: 0,195
  28. High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003 Mar; 23(1):15-23.
    View in: PubMed
    Score: 0,179
  29. Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021. Vaccine. 2022 07 30; 40(32):4283-4291.
    View in: PubMed
    Score: 0,171
  30. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 2022 Jun; 10(6):e807-e819.
    View in: PubMed
    Score: 0,169
  31. Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies. BMC Med Res Methodol. 2022 03 27; 22(1):85.
    View in: PubMed
    Score: 0,168
  32. Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates. Vaccine. 2020 10 07; 38(43):6682-6694.
    View in: PubMed
    Score: 0,151
  33. Neurodevelopmental Impairment at 1 Year of Age in Infants With Previous Invasive Group B Streptococcal Sepsis and Meningitis. Pediatr Infect Dis J. 2020 09; 39(9):794-798.
    View in: PubMed
    Score: 0,151
  34. Clinical and Molecular Epidemiology of Invasive Group B Streptococcus Disease among Infants, China. Emerg Infect Dis. 2019 11; 25(11):2021-2030.
    View in: PubMed
    Score: 0,142
  35. Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions. Vaccine. 2019 08 14; 37(35):4877-4885.
    View in: PubMed
    Score: 0,139
  36. The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vaccine. 2019 05 27; 37(24):3190-3198.
    View in: PubMed
    Score: 0,137
  37. Serocorrelates of protection against infant group B streptococcus disease. Lancet Infect Dis. 2019 05; 19(5):e162-e171.
    View in: PubMed
    Score: 0,135
  38. Knowledge gaps among South African healthcare providers regarding the prevention of neonatal group B streptococcal disease. PLoS One. 2018; 13(10):e0205157.
    View in: PubMed
    Score: 0,132
  39. Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine. 2019 11 28; 37(50):7391-7393.
    View in: PubMed
    Score: 0,126
  40. Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S89-S99.
    View in: PubMed
    Score: 0,124
  41. Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S143-S151.
    View in: PubMed
    Score: 0,124
  42. Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S152-S159.
    View in: PubMed
    Score: 0,124
  43. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S160-S172.
    View in: PubMed
    Score: 0,124
  44. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S100-S111.
    View in: PubMed
    Score: 0,124
  45. Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S112-S124.
    View in: PubMed
    Score: 0,124
  46. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S133-S142.
    View in: PubMed
    Score: 0,124
  47. Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S173-S189.
    View in: PubMed
    Score: 0,124
  48. Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S190-S199.
    View in: PubMed
    Score: 0,124
  49. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S200-S219.
    View in: PubMed
    Score: 0,124
  50. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016. Vaccine. 2019 11 28; 37(50):7307-7314.
    View in: PubMed
    Score: 0,117
  51. Challenges in reducing group B Streptococcus disease in African settings. Arch Dis Child. 2017 Jan; 102(1):72-77.
    View in: PubMed
    Score: 0,115
  52. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children. Vaccine. 2016 10 17; 34(44):5217-5224.
    View in: PubMed
    Score: 0,115
  53. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016 08; 16(8):923-34.
    View in: PubMed
    Score: 0,112
  54. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016 May; 16(5):546-555.
    View in: PubMed
    Score: 0,110
  55. Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study. BMC Pediatr. 2015 Oct 01; 15:143.
    View in: PubMed
    Score: 0,107
  56. Maternal group B Streptococcus-related stillbirth: a systematic review. BJOG. 2015 Oct; 122(11):1437-45.
    View in: PubMed
    Score: 0,106
  57. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines. 2015 Jan; 14(1):135-49.
    View in: PubMed
    Score: 0,100
  58. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine. 2014 Apr 07; 32(17):1954-63.
    View in: PubMed
    Score: 0,096
  59. Evaluation of Trans-Vag broth, colistin-nalidixic agar, and CHROMagar StrepB for detection of group B Streptococcus in vaginal and rectal swabs from pregnant women in South Africa. J Clin Microbiol. 2013 Aug; 51(8):2515-9.
    View in: PubMed
    Score: 0,091
  60. Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol. 2013 Feb; 62(Pt 2):249-253.
    View in: PubMed
    Score: 0,087
  61. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012 Jul; 55(1):91-102.
    View in: PubMed
    Score: 0,085
  62. The antimicrobial activity of zinc against group B Streptococcus is strain-dependent across diverse sequence types, capsular serotypes, and invasive versus colonizing isolates. BMC Microbiol. 2022 01 13; 22(1):23.
    View in: PubMed
    Score: 0,041
  63. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009 Dec 05; 374(9705):1909-16.
    View in: PubMed
    Score: 0,018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.